View of Safety and Tolerance of Prostaglandin E1 Therapy in Neonates with Duct-Dependent Congenital Heart Disease: A 10-Year Retrospective Study

Return to Issue Details Safety and Tolerance of Prostaglandin E1 Therapy in Neonates with Duct-Dependent Congenital Heart Disease: A 10-Year Retrospective Study Download Download PDF